Activation of the EGFR/PI3K/AKT pathway limits the efficacy of trametinib treatment in head and neck cancer - Novoplansky, Ofra; Shnerb, Avital B.; Marripati, Divyasree; Jagadeeshan, Sankar; Abu Shareb, Raghda; Conde-Lopez, Cristina; Zorea, Jonathan; Prasad, Manu; Ben Lulu, Talal; Yegodayev, Ksenia M.; Benafsha, Chen; Li, Yushi; et al. (Molecular oncology, 2023)
Gesehen am 14.11.2023